Published in Eur J Biochem on May 15, 1986
Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci (2003) 1.68
Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. EMBO J (1987) 1.60
The crystal structures of the open and catalytically competent closed conformation of Escherichia coli glycogen synthase. J Biol Chem (2009) 1.18
Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate. Protein Sci (1992) 0.83
Multiple phosphate positions in the catalytic site of glycogen phosphorylase: structure of the pyridoxal-5'-pyrophosphate coenzyme-substrate analog. Protein Sci (1992) 0.83
Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals. Protein Sci (1994) 0.82
The binding of D-gluconohydroximo-1,5-lactone to glycogen phosphorylase. Kinetic, ultracentrifugation and crystallographic studies. Biochem J (1991) 0.79
cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem (1994) 2.95
Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50
The role of oxygen-free radicals in ischemic tissue injury in island skin flaps. Ann Surg (1983) 1.64
3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol (1996) 1.63
Alpha 1-adrenergic receptor coupling with Gh in the failing human heart. Circulation (1996) 1.50
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. J Pharmacol Exp Ther (1988) 1.32
Calibres of aorta and pulmonary artery in hypoplastic left and right heart syndromes: effects of abnormal bloodflow? Virchows Arch A Pathol Anat Histol (1974) 1.28
The role of pyridoxal 5'-phosphate in glycogen phosphorylase catalysis. Biochemistry (1990) 1.21
Evolution of catalytic and regulatory sites in phosphorylases. Nature (1985) 1.19
Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Anal Biochem (1995) 1.18
Normal internal calibres of ostia of great arteries and of aortic isthmus in infants and children. Br Heart J (1977) 1.17
Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Eur J Clin Pharmacol (1985) 1.15
The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase. EMBO J (1997) 1.14
Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem (1996) 1.11
Energy metabolism in healing skin wounds. J Surg Res (1970) 1.10
Escherichia coli maltodextrin phosphorylase: contribution of active site residues glutamate-637 and tyrosine-538 to the phosphorolytic cleavage of alpha-glucans. Biochemistry (1990) 1.07
Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J Immunol (1998) 1.07
The role of oxygen free radicals in mediating the reperfusion injury of cold-preserved ischemic kidneys. Transplantation (1985) 1.05
Substrate-cofactor interactions for glycogen phosphorylase b: a binding study in the crystal with heptenitol and heptulose 2-phosphate. Biochemistry (1984) 1.04
Differentiation of beta 1- and beta 2-adrenoceptor-mediated effects in humans. Am J Physiol (1988) 1.04
Oligosaccharide substrate binding in Escherichia coli maltodextrin phosphorylase. Nat Struct Biol (1997) 1.04
Fixation of the craniofacial skeleton with butyl-2-cyanoacrylate and its effects on histotoxicity and healing. Plast Reconstr Surg (1998) 1.03
High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett (1999) 1.03
Tissue glucose and lactate following vascular occlusion in island skin flaps. Plast Reconstr Surg (1982) 1.01
The effects of hyperbaric oxygen on free flaps in rats. Arch Surg (1990) 1.01
Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.99
Multisite contacts involved in coupling of the beta-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by beta-receptor-site-specific synthetic peptides. Eur J Biochem (1991) 0.99
Regulation of signal transfer from beta 1-adrenoceptor to adenylate cyclase by beta gamma subunits in a reconstituted system. Eur J Biochem (1987) 0.98
Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem (1999) 0.97
Reconstitution of beta-adrenergic receptor with components of adenylate cyclase. EMBO J (1984) 0.97
Enteroaggregative, Shiga toxin-producing Escherichia coli O104:H4 outbreak: new microbiological findings boost coordinated investigations by European public health laboratories. Euro Surveill (2011) 0.95
General acid-base catalysis of alpha-glucan phosphorylases: stereospecific glucosyl transfer from D-glucal is a pyridoxal 5'-phosphate and orthophosphate (arsenate) dependent reaction. Biochemistry (1982) 0.94
Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J Biol Chem (1995) 0.94
The role of pyridoxal phosphate in the catalysis of glycogen phosphorylases. Angew Chem Int Ed Engl (1980) 0.93
Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle. Circ Res (1994) 0.93
A syndrome of short stature, amimic facies, enamel hypoplasia, slowly progressive stiffness of the joints and high-pitched voice in two siblings. J Pediatr (1977) 0.92
Identification of tyrosine phosphorylation sites in human Gab-1 protein by EGF receptor kinase in vitro. Biochemistry (1999) 0.92
Growth of the internal diameters in the pulmonary arterial tree in infants and children. J Anat (1987) 0.92
Effects of superoxide dismutase and allopurinol on the survival of acute island skin flaps. Ann Surg (1985) 0.92
Congenital muscular dystrophy, brain malformation and ocular problems (muscle, eye and brain disease) in two German families. Eur J Pediatr (1984) 0.92
Identification and quantification of beta-adrenoceptors sites in red blood cells from rats. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.91
Effects of Mg2+, Mn2+ and Ca2+ on adenylcyclase activity. Evidence for a metallic site. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.91
Effect of allopurinol on the survival of hyperemic island skin flaps. Plast Reconstr Surg (1984) 0.91
Dimerization-induced activation of soluble insulin/IGF-1 receptor kinases: an alternative mechanism of activation. Biochemistry (2001) 0.91
Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man. Eur J Clin Pharmacol (1993) 0.91
A case of tetralogy of Fallot with pulmonary atresia and restrictive perimembranous ventricular septal defect. Thorac Cardiovasc Surg (1997) 0.90
Tunica media of aorta and pulmonary trunk in relation to internal calibres in transposition of great arteries, in aortic and pulmonary atresia and in normal hearts. Virchows Arch A Pathol Anat Histol (1980) 0.90
Oxytocin receptor couples to the 80 kDa Gh alpha family protein in human myometrium. Biochem J (1996) 0.89
Chemical and functional analysis of components of adenylyl cyclase from human platelets treated with phorbolesters. FEBS Lett (1991) 0.89
[Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.89
[Influence of recurrent hypoglycemia on the EEG of the diabetic child]. Monatsschr Kinderheilkd (1969) 0.89
N-acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke (1995) 0.89
Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry (1999) 0.88
[Catecholamines and other sympathomimetic amines. Biosynthesis and inactivation. Liberation and action]. Ergeb Physiol (1966) 0.88
Reconstitution of beta 1-adrenoceptor-dependent adenylate cyclase from purified components. EMBO J (1986) 0.88
Secretory antibodies against Giardia intestinalis in lactating Nicaraguan women. Parasite Immunol (2005) 0.88
Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Eur Heart J (1987) 0.87
Nosology of congenital non-progressive cerebellar ataxia. Report on six cases in three families. Neuropadiatrie (1974) 0.87
Negative response elements in keratin genes mediate transcriptional repression and the cross-talk among nuclear receptors. J Biol Chem (2001) 0.87
Does pyridoxal 5'-phosphate function in glycogen phosphorylase as an electrophilic or a general acid catalyst? Biochemistry (1984) 0.87
Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene. J Neurol Neurosurg Psychiatry (2003) 0.87
Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers. Arzneimittelforschung (1985) 0.86
Dynamic responses to intravenous urapidil and dihydralazine in normal subjects. Clin Pharmacol Ther (1985) 0.86
Comparison of the growth of the tunica media of the ascending aorta, aortic isthmus and descending aorta in infants and children. J Anat (1983) 0.86
Affinity and selectivity of beta-adrenoceptor antagonists in vitro. J Cardiovasc Pharmacol (1986) 0.85
Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem (2000) 0.85
Dissecting differential binding in the forward and reverse reaction of Escherichia coli maltodextrin phosphorylase using 2-deoxyglucosyl substrates. J Biol Chem (1994) 0.85
Quantitative histochemistry of the primate skin. VI. Lactate dehydrogenase. J Invest Dermatol (1966) 0.85
Primary rhabdomyosarcoma of the leptomeninx. Clinical, neuroradiological and pathological aspects. Clin Neurol Neurosurg (1984) 0.85
Enzymes of carbohydrate metabolism in normal human sebaceous glands. J Invest Dermatol (1974) 0.84
Amino-acid sequence of the pyridoxal-phosphate-binding site in Escherichia coli maltodextrin phosphorylase. Eur J Biochem (1978) 0.84
Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy. Eur J Clin Pharmacol (1986) 0.84
Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013. Euro Surveill (2014) 0.84
Correlation between isoprenaline-stimulated synthesis of cyclic AMP and occurrence of beta-adrenoreceptors in immature erythrocytes from rats. Eur J Pharmacol (1978) 0.84
Evidence that the Gh protein is a signal mediator from alpha 1-adrenoceptor to a phospholipase C. I. Identification of alpha 1-adrenoceptor-coupled Gh family and purification of Gh7 from bovine heart. J Biol Chem (1993) 0.84
Mutational analysis of the oligosaccharide recognition site at the active site of Escherichia coli maltodextrin phosphorylase. Biochemistry (1996) 0.84
Quantitative histochemistry of the primate skin. V. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. J Invest Dermatol (1966) 0.84
[Quantitative parameters of sympatho-neuronal and sympatho-adrenal activities in man. The influence of beta-receptor blocking agents (author's transl)]. Arzneimittelforschung (1977) 0.83
Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans. Clin Pharmacol Ther (1994) 0.83
Effects of deferoxamine on ischemia/reperfusion injury after peripheral nerve compression. Ann Plast Surg (1996) 0.83
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay. J Cardiovasc Pharmacol (1986) 0.83
Noradrenaline depleting effect and metabolism of oxyfedrine in rats. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.82
E. coli maltodextrin phosphorylase: primary structure and deletion mapping of the C-terminal site. Z Naturforsch C (1987) 0.82
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm Park Dis Dement Sect (1994) 0.82
Expression, purification, and characterization of the cytoplasmic domain of the human IGF-1 receptor using a baculovirus expression system. Biochem Biophys Res Commun (1999) 0.82
Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.82
Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library. Nat Biotechnol (1999) 0.82
Occurrence of adenyl cyclase activity in human erythrocytes. Blut (1974) 0.81
Free radical damage in acute nerve compression. Ann Plast Surg (1995) 0.81
Enzyme activities in the repairing epithelium during wound healing. J Surg Res (1970) 0.81
Rabbit muscle phosphorylase derivatives with oligosaccharides covalently bound to the glycogen storage site. Biochemistry (1982) 0.81
Conformation of a beta-adrenoceptor-derived signal transducing peptide as inferred by circular dichroism and 1H NMR spectroscopy. Biochemistry (1996) 0.81
Evidence for an early free radical-mediated reperfusion injury in frostbite. Free Radic Biol Med (1991) 0.81
Effects of hyperbaric oxygen and hyperbaric air on the survival of island skin flaps. Plast Reconstr Surg (1984) 0.80